Furthermore, combining US morphological characteristics with patient’s age, risk factors (previous history of testicular cancer, testicular dysgenesis syndromes such as cryptorchidism, testicular atrophy, mumps orchitis, family history) and tumour markers (AFP, bHCG, LDH) may enable the development of predictive models of tumour type. The gene discussed is AFP; the disease is testicular dysgenesis syndrome.